Propylthiouracil and Hepatitis
- 1 May 1984
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 144 (5), 994-996
- https://doi.org/10.1001/archinte.1984.00350170148025
Abstract
• Propylthiouracil-induced hepatitis is an uncommon entity. Two further cases are reported herein, and the clinical and laboratory features of the other six cases in the English literature are reviewed. The initial appearance of the disease is similar to that of viral hepatitis, characterized by nausea, vomiting, and jaundice. The biochemical pattern of injury is predominantly hepatocellular, with marked elevation of transaminase valves and less striking elevation of alkaline phosphatase values. Recovery is usually complete after withdrawal of the drug, but there have been at least two fatalities, including the first patient (to our knowledge) whose case is reported herein. Despite its rarity, the disease should be suspected in any patient receiving propylthiouracil in whom clinical or laboratory evidence of hepatocellular injury develops. (Arch Intern Med 1984;144:994-996)Keywords
This publication has 8 references indexed in Scilit:
- Hepatic Lesions Caused by Anabolic and Contraceptive SteroidsSeminars in Liver Disease, 1981
- Hepatitis and PropylthiouracilAnnals of Internal Medicine, 1975
- Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapyThe Journal of Pediatrics, 1970
- Unwanted effects of propranololThe American Journal of Cardiology, 1966
- Fulminant Hepatitis during Treatment with PropylthiouracilNew England Journal of Medicine, 1953
- PROPYLTHIOURACIL-INDUCED AGRANULOCYTOSIS, TOXIC HEPATITIS, AND DEATHJAMA, 1952
- FATAL AGRANULOCYTOSIS OCCURRING DURING PROPYLTHIOURACIL THERAPYJAMA, 1949
- AGRANULOCYTOSIS AND HEPATOCELLULAR JAUNDICEJAMA, 1947